Simultaneous treatment of anterior @entity3133 and stress @entity322 by using transobturator four arms XXXX mesh.

@entity1 @entity322 @entity7502 @entity3133 @entity546
PURPOSE: To evaluate the medium-term efficacy and safety of transobturator four-arm @entity7502 mesh in the treatment of high-stage anterior @entity3133 and concomitant stress @entity322 (SUI). MATERIALS AND METHODS: Between September 2010 and August 2013, a prospective single-center trial was performed to evaluate @entity1 with stage>= 3 anterior @entity3133 with or without SUI who presented to Labbafinejad Hospital, Teheran, Iran, and underwent anterior vaginal wall repair with @entity7502 mesh. Pre- and postoperative evaluation included history; physical examination using the Pelvic Organ Prolapse Quantification system and cough stress test, both before and after reduction of prolapsed structures; Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ); urinalysis and culture; and a postvoid residual assessment. Complications were reported at a mean of 2 years of follow-up. RESULTS: A total of 71 @entity1 underwent cystocele repair with the transobturator four-arm @entity7502 mesh. Seven of the @entity1 were lost to follow-up. There were no perioperative complications. The anatomical success rate was 87.5%. The subjective success rate was 92.1%. The PFDI and PFIQ were significantly improved after surgery (p<0.001). Among those with the simultaneous complaint of SUI, 82% were cured without any additional procedure. Three @entity1 (4.6%) experienced vaginal mesh extrusion. Two @entity1 (3.1%) reported worsening of @entity546 after surgery. CONCLUSIONS: The four arms @entity7502 mesh is an effective device for simultaneous correction of anterior @entity3133 and SUI with a low complication rate at a medium-term follow-up. The majority of the subgroup with concomitant SUI were cured without a second simultaneous procedure.
